SecBot SecBot

IRWD

IRONWOOD PHARMACEUTICALS INC
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001446847 Biotech & Drug Discovery
$4.85 +0.02 (+0.41%)
Nov 16 4:00 PM ET · prev $4.83
Market cap
$802.9M
Small cap
Median target
$5.50
+13% · range $3.70–10.00
1 year
+55.0%
from $3.13 · Nov 17
30 days
+36.2%
from $3.56
52-week range
$3.04–5.39
−10% from high · low Mar 20
Avg volume 20D
2.47M
shares / day
Short interest
14.86M
≈9.0% of shares · −6.5%
Days to cover
9.8
at average volume
Insider net
−$22.1M
0 buyers · 6 sellers · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
13
analyzed by SecBot
SecBot read BULLISH 7 reports · 90 days
Balance 0 bearish · 1 bullish · 6 neutral oldest → newest, height = score
Avg score ·High conf. 5/7

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    6 insiders sold $22.1M.

  • InstitutionsBULLISH

    Q3 2026: 24 added (0 new), 12 trimmed or exited.

  • EstimatesFLAT

    Current-quarter EPS estimate $0.393 → $0.390 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest −6.5% to 14.86M shares. 9.8 days to cover, ≈9.0% of shares.

  • TrendUPTREND

    22% above its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 6.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
MARSHALL WACE, LLPTRIM2,567,468$10.2M
O'SHAUGHNESSY ASSET MANAGEMENT, LLCDOUBLED1,376,610$5.2M
FMR LLCADD1,252,126$5.0M
FRANKLIN TEMPLETON INCADD1,268,533$4.8M
HRT FINANCIAL LPADD1,085,441$4.3M
Qube Research & Technologies LtdDOUBLED865,395$3.4M
Nuveen, LLCADD487,004$1.9M
PRINCIPAL FINANCIAL GROUP INCDOUBLED318,883$1.3M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Feb 2026
12-month targets · 4 analysts

Price is inside the target range. Median implies +13%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Feb 26, 2026Citizens
MAINTAIN
MAINTAINMarket Outperform
Jan 5, 2026Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Jan 5, 2026Citizens
UPGRADE
UPGRADEMarket Outperform
Nov 11, 2025Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Apr 15, 2025Wells Fargo
DOWNGRADE
DOWNGRADEEqual-Weight
Apr 15, 2025Jefferies
DOWNGRADE
DOWNGRADEHold

Insider ledger

Form 4
$0
bought · 0 insiders
$22.1M
sold · 6 insiders
DateInsiderTypeValue
Sep 15, 2026
DENNER ALEXANDER J
Director
Sep 15, 2026
AWARD3,694 sh
Jul 20, 2026
Silber Jeffrey
SVP, CMO, Head-Res&Drug
Jul 20, 2026
AWARD137,036 sh
Jul 7, 2026
Silver Ronald
PFO & PAO
Jul 7, 2026
SELL$578.1K
Jun 16, 2026
Duane Jon R
Director
Jun 16, 2026
AWARD63,481 sh
Jun 16, 2026
Kessler Marla L
Director
Jun 16, 2026
AWARD63,481 sh
Jun 16, 2026
Moukheibir Catherine
Director
Jun 16, 2026
AWARD63,481 sh
Jun 16, 2026
Currie Mark G
Director
Jun 16, 2026
AWARD63,481 sh
Jun 16, 2026
Shepard Jay
Director
Jun 16, 2026
AWARD63,481 sh

Earnings setup

Estimates
$0.39
EPS estimate, this quarter
−1%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.39$0.37–$0.41+14.7%$136.2M
Next Q$0.30$0.26–$0.35+3.4%$108.9M
Current FY🔒 Fresh data, subscribers only
Next FY$1.57$1.36–$1.82+4.4%$504.2M
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Short side

FINRA· Oct 30, 2026
14,860,120
shares short
-6.5%
vs prior settlement
9.8
days to cover
≈9.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 13, 2026 SEC
Tammi Gaskins, an officer of Ironwood Pharmaceuticals, filed a Form 144 notice of intent to sell 6,666 shares of Class…
144 · Impact 2/10
Nov 10, 2026 SEC
State Street Corp filed a Schedule 13G disclosing a passive 4.1% stake (6,723,774 shares) in Ironwood Pharmaceuticals…
SC 13G · Impact 3/10
Nov 5, 2026 Earnings result
IRWD Q3 2026 Earnings: EPS $0.36 (+9.2% vs est)
Sep 30, 2026 Inst.
MARSHALL WACE, LLP · TRIM
2,567,468 shares ($10.2M)
Sep 30, 2026 Inst.
O'SHAUGHNESSY ASSET MANAGEMENT, LLC · DOUBLED
1,376,610 shares ($5.2M)
Sep 15, 2026 Insider
DENNER ALEXANDER J was granted 3,694 shares
Director
Jul 20, 2026 Insider
Silber Jeffrey was granted 137,036 shares
SVP, CMO, Head-Res&Drug
Reddit Mentions per day, 14 days
Recent posts
All social signals and their track records

SecBot reports

13 filings · 3 bullish · 3 bearish · 1 mixed · 6 neutral
All IRWD filing & press-release reports (13)